Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 10999 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anagnostis, P., Karras S. N., Vakalopoulou S., & Terpos E. (2016).  Haemophilia and low bone mass. Ok, but what about fracture risk?. Haemophilia. 22(1), 11-4.
Anagnostis, P., Karagiannis A., Tziomalos K., Kakafika A. I., Athyros V. G., & Mikhailidis D. P. (2009).  Adrenal incidentaloma: a diagnostic challenge.. Hormones (Athens). 8(3), 163-84.
Anagnostis, P., Bosdou J. K., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2020).  Vitamin D supplementation and fracture risk: Evidence for a U-shaped effect.. Maturitas. 141, 63-70.
Anagnostis, P., Paschou S. A., & Goulis D. G. (2018).  Management of Acute Hip Fracture.. N Engl J Med. 378(10), 971-2.
Anagnostis, P., Papanikolaou D., Ioannidou P. G., Bosdou J. K., Mikhailidis D. P., Hatzimouratidis K., et al. (2021).  The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic review.. Andrology. 9(5), 1504-1511.
Anagnostis, P., Siolos P., Christou K., Gkekas N. K., Kosmidou N., Athyros V. G., et al. (2018).  The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data.. Hormones (Athens). 17(1), 83-95.
Anagnostis, P., Paschou S. A., Kenanidis E., Lambrinoudaki I., Potoupnis M., Tsiridis E., et al. (2019).  "Holidays" for osteoporosis drugs: A case-based approach.. Case Rep Womens Health. 23, e00127.
Anagnostis, P., Karagiannis A., Tziomalos K., Athyros V. G., Kita M., & Mikhailidis D. P. (2010).  Endocrine hypertension: diagnosis and management of a complex clinical entity.. Curr Vasc Pharmacol. 8(5), 646-60.
Anagnostis, P., Vakalopoulou S., Karras S., Charizopoulou M., & Garipidou V. (2014).  The role of arthropathy in the development of osteoporosis in patients with haemophilia: do we need more?. Haemophilia. 20(1), e83-5.
Anagnostis, P., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Impact of statins on glucose metabolism--a matter of debate.. Am J Cardiol. 107(12), 1866.
Anagnostis, P., Karras S. N., Athyros V. G., Mikhailidis D. P., & Karagiannis A. (2014).  Subclinical Cushing's syndrome and cardiovascular disease.. Lancet Diabetes Endocrinol. 2(5), 361.
Anagnostis, P., Paschou S. A., Gkekas N. N., Artzouchaltzi A-M., Christou K., Stogiannou D., et al. (2018).  Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.. Endocrine. 60(3), 373-383.
Anagnostis, P., Katsiki N., Adamidou F., Athyros V. G., Karagiannis A., Kita M., et al. (2013).  11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?. Metabolism. 62(1), 21-33.
Anagnostis, P., Efstathiadou Z., Polyzos S. A., Tsolakidou K., Litsas I. D., Panagiotou A., et al. (2010).  Long term follow-up of patients with adrenal incidentalomas--a single center experience and review of the literature.. Exp Clin Endocrinol Diabetes. 118(9), 610-6.
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.. Curr Med Res Opin. 1-10.
Anagnostis, P., & Goulis D. G. (2019).  Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease".. J Clin Endocrinol Metab. 104(8), 3124.
Anagnostis, P., & Goulis D. G. (2020).  Cushing's Syndrome and Cardiovascular Risk.. Curr Vasc Pharmacol. 18(1), 25-26.
Anagnostis, P., Karras S., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2016).  Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.. Int J Clin Pract. 70(12), 967-977.
Anagnostis, P., Christou K., Artzouchaltzi A-M., Gkekas N. K., Kosmidou N., Siolos P., et al. (2019).  Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis.. Eur J Endocrinol. 180(1), 41-50.
Anagnostis, P., Florou P., Bosdou J. K., Grimbizis G. F., Iakovou I., Kolibianakis E. M., et al. (2021).  Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.. Maturitas. 148, 40-45.
Anagnostis, P., Athyros V. G., Adamidou F., Florentin M., & Karagiannis A. (2010).  Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?. Curr Vasc Pharmacol. 8(5), 720-30.
Anagnostis, P., Vakalopoulou S., Charizopoulou M., Kazantzidou E., Chrysopoulou T., Moka E., et al. (2013).  Is there any association between leptin levels and bone mineral density in haemophiliac men?. Arch Med Sci. 9(3), 459-65.
Anagnostis, P., Paschou S. A., & Goulis D. G. (2018).  Calcium and Vitamin D Supplements and Fractures in Community-Dwelling Adults.. JAMA. 319(19), 2041.
Anagnostis, P., Theocharis P., Lallas K., Konstantis G., Mastrogiannis K., Bosdou J. K., et al. (2020).  Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis.. Maturitas. 135, 74-79.
Anagnostis, P., Bosdou J. K., Vaitsi K., Goulis D. G., & Lambrinoudaki I. (2020).  Estrogen and bones after menopause: a reappraisal of data and future perspectives.. Hormones (Athens).

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές